Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.8K Sell
28,638
-268
-0.9% -$407 ﹤0.01% 1354
2026
Q1
$52.3K Sell
28,906
-2,674
-8% -$4.62K ﹤0.01% 1217
2025
Q4
$42.6K Sell
31,580
-31
-0.1% -$44 ﹤0.01% 1194
2025
Q3
$51.5K Sell
31,611
-8,843
-22% -$9.8K ﹤0.01% 1176
2025
Q2
$39.8K Buy
+40,454
New +$33.6K ﹤0.01% 1196

Other funds holding OCGN

Ethic Inc's OCGN Position: Q2 2026 in Review

Ethic Inc reduced its Ocugen (OCGN) stake by 0.93% in Q2 2026, selling an estimated $407 and leaving 28,638 shares worth $43.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

Ethic Inc first reported a position in OCGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $52.3K in Q1 2026. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Ethic Inc held 28,638 shares of Ocugen worth $43.8K as of Q2 2026.
  • Ethic Inc sold 268 Ocugen shares in Q2 2026, an estimated $407.
  • Ocugen made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1354 holding.
  • Ethic Inc first reported a position in Ocugen in Q2 2025 and has held it in 5 quarters since.
  • Ethic Inc's Ocugen position peaked at $52.3K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.